MiR-873 functions as a potential tumor suppressor in pancreatic cancer by targeting KRAS

被引:0
|
作者
Mokhlis, Hamada A. [1 ]
Bayraktar, Recep [1 ]
Kabil, Nashwa N. [1 ]
Kahraman, Nermin [1 ]
Bouchard, Richard [1 ]
Abdelghany, Tamer [2 ]
Ashour, Ahmed [2 ]
Abdel-Aziz, Abdel-Aziz H. [2 ]
Calin, George A. [1 ]
Lopez-Berestein, Gabriel [1 ]
Ozpolat, Bulent [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Al Azhar Univ, Fac Pharm, Cairo, Egypt
关键词
D O I
10.1158/1538-7445.AM2018-507
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
507
引用
收藏
页数:2
相关论文
共 50 条
  • [31] RETRACTION: MiR-137 functions as a tumor suppressor in pancreatic cancer by targeting MRGBP (Retraction of Vol 119, Pg 4799, 2018)
    Ding, Feng
    Zhang, Shuang
    Gao, Shaoyang
    Shang, Jian
    Li, Yanxia
    Cui, Ning
    Zhao, Qiu
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2024, 125 (05)
  • [32] Targeting KRAS in Pancreatic Cancer
    Cowzer, Darren
    Zameer, Mohammed
    Conroy, Michael
    Kolch, Walter
    Duffy, Austin G.
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (11):
  • [33] Targeting KRAS in pancreatic cancer
    Stickler, Sandra
    Rath, Barbara
    Hamilton, Gerhard
    ONCOLOGY RESEARCH, 2024, 32 (05) : 799 - 805
  • [34] TNNT1, negatively regulated by miR-873, promotes the progression of colorectal cancer
    Chen, Yu
    Wang, Jinsong
    Wang, Donghua
    Kang, Ting
    Du, Jinghu
    Yan, Zeqiang
    Chen, Manyu
    JOURNAL OF GENE MEDICINE, 2020, 22 (02):
  • [35] Loss of miR-873 contributes to gemcitabine resistance in triple-negative breast cancer via targeting ZEB1
    Wang, Gangyue
    Dong, Yi
    Liu, Heng
    Ji, Nan
    Cao, Jilei
    Liu, Aihui
    Tang, Xin
    Ren, Yu
    ONCOLOGY LETTERS, 2019, 18 (04) : 3837 - 3844
  • [36] Norcantharidin regulates ERα signaling and tamoxifen resistance via targeting miR-873/CDK3 in breast cancer cells
    Zhang, Xiumei
    Zhang, Bingfeng
    Zhang, Panhong
    Lian, Lihui
    Li, Lianlian
    Qiu, Zhihong
    Qian, Kai
    Chen, An
    Liu, Qiongqing
    Jiang, Yinjie
    Cui, Jiajun
    Qi, Bing
    PLOS ONE, 2019, 14 (05):
  • [37] MiR-873 regulates ERα transcriptional activity and tamoxifen resistance via targeting CDK3 in breast cancer cells
    Cui, J.
    Yang, Y.
    Li, H.
    Leng, Y.
    Qian, K.
    Huang, Q.
    Zhang, C.
    Lu, Z.
    Chen, J.
    Sun, T.
    Wu, R.
    Sun, Y.
    Song, H.
    Wei, X.
    Jing, P.
    Yang, X.
    Zhang, C.
    ONCOGENE, 2015, 34 (30) : 3895 - 3907
  • [38] Circular RNA DGKB Promotes the Progression of Neuroblastoma by Targeting miR-873/GLI1 Axis
    Yang, Jiale
    Yu, Leitao
    Yan, Jinlong
    Xiao, Yu
    Li, Weiming
    Xiao, Juhua
    Lei, Jun
    Xiang, Deng
    Zhang, Shouhua
    Yu, Xin
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [39] miR-873 and miR-105-2 May Affect the Tumour Microenvironment and are Potential Biomarkers for Lung Adenocarcinoma
    Zhang, Hao
    Liu, Yan
    Xu, Zhihong
    Chen, Quan
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2022, 15 : 3433 - 3445
  • [40] MiR-873/PD-L1 axis regulates the stemness of breast cancer cells
    Gao, Lanlan
    Guo, Qianqian
    Li, Xiaoman
    Yang, Xuan
    Ni, Haiwei
    Wang, Ting
    Zhao, Qiong
    Liu, Hai
    Xing, Yingying
    Xi, Tao
    Zheng, Lufeng
    EBIOMEDICINE, 2019, 41 : 395 - 407